#BEGIN_DRUGCARD DB04045

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
15465

# Chemical_Formula:
C25H40N7O19P3S

# Chemical_IUPAC_Name:
(2R)-3-[(2-{3-[(2S)-3-[({[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido]propanamido}ethyl)sulfanyl]-2-methyl-3-oxopropanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Methylmalonyl-Coenzyme A

# HET_ID:
MCA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t12-,13+,16-,17+,18-,22-/m1/s1

# InChI_Key:
InChIKey=MZFOKIKEPGUZEN-MVQIFZLOSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4045

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
867.607

# Molecular_Weight_Mono:
867.131252359

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1ON3

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.6

# Predicted_LogS:
-2.4

# Predicted_Water_Solubility:
3.57e+00 g/l

# Primary_Accession_No:
DB04045

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936873

# PubChem_Substance_ID:
46507986

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02132

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@H](C(O)=O)C(=O)SCCNC(=O)CCNC(=O)[C@@H](O)C(C)(C)CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:53 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L04196

# Drug_Target_1_GenBank_ID_Protein:
150933

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>1818 bp
ATGGCTGAAAACAACAATTTGAAGCTCGCCAGCACCATGGAAGGTCGCGTGGAGCAGCTC
GCAGAGCAGCGCCAGGTGATCGAAGCCGGTGGCGGCGAACGTCTCGTCGAGAAGCAACAT
TCCCAGGGTAAGCAGACCGCTCGTGAGCGCCTGAACAACCTGCTCGATCCCCATTCGTTC
GACGAGGTCGGCGCTTTCCGCAAGCACCGCACCACGTTGTTCGGCATGGACAAGGCCGTC
GTCCCGGCAGATGGCGTGGTCACCGGCCGTGGCACCATCCTTGGTCGTCCCGTGCACGCC
GCGTCCCAGGACTTCACGGTCATGGGTGGTTCGGCTTGGCGAGACGCAGTCCACGAAGGT
CGTCGAGACGATGGAACAGCGCTGCTCACCGGCACGCCCTTCCTGTTCTTCTACGATTCG
GGCGGCCGGATCCAGGAGGGCATCGACTCGCTGAGCGGTTACGGCAAGATGTTCTTCGCC
AACGTGAAGCTGTCGGGCGTCGTGCCGCAGATCGCCATCATTGCCGGCCCCTGTGCGTGC
GCCTCGTATTCGCCGGCACTGACTGACTTCATCATCATGACCAAGAAGGCCCATATGTTC
ATCACGGGCCCCCAGGTCATCAAGTCGGTCACCGGCGAGGATGTCACCGCTGACGAACTC
GGTGGCGCTGAGCCCATATGGCCATCTCGGGCAATATACTTCGTGGCCGAGGACGACGAC
GCCGCGGAGCTCATTGCCAAGAAGCTGCTGAGCTTCCTTCCGCAGAACAACACTGAGGAA
GCATCCTTCGTCAACCCGAACAATGACGTCAGCCCCAATACCGAGCTGCGCGACATCGTT
CCGATTGACGGCAAGAAGGGCTATGACGTGCGCGATGTCATTGCCAAGATCGTCGACTGG
GGTGACTACCTCGAGGTCAAGGCCGGCTATGCCACCAACCTCGTGACCGCCTTCGCCCGG
GTCAATGGTCGTTCGGTGGGCATCGTGGCCAATCAGCCTTCGGTGATGTCGGGTTGCCTC
GACATCAACGCCTCTGACAAGGCCGCCGAATTCGTGAATTTCTGCGATTCGTTCAACATC
CCGCTGGTGCAGCTGGTCGACGTGCCGGGCTTCCTGCCCGTGCAGCAGGAGTACGGCGGC
ATCATTCGCCATGGGCGCAAGATGCTGTACGCCTACTCCGAGGCCACCGTGCCGAAGATC
ACGTGTCTCGCAACGCCTACGGCGGCTCCTACCTGGCCATGTGCAACCGTGACCTTGGTG
CCGACGCCGTGTACGCCTGTGCCCAGCGCCGAGATTGCGGTGATGGGCGCCGAGGGTGCG
GCAAATGTGATCTTCCGCAAGGAGATCAAGGCTGCCGACGATCCCGACGCCATGCGCGCC
GAGAAGATCGAGGAGTACCAGAACGGTTCAACACGCCGTACGTGGCGCGCCCGCGGTCAG
GTCGACGACGTGATTGACCCGGCTGATACCCGTCGAAAGATTGCTTCCGCCCTGGAGATG
TACGCCACCAAGCGTCAGACCCGCCCGGCGAAGAAGCCATGGAAACTTCCCCTGCTGAGC
GAGGAGGAAATTATGGCTGATGAGGAAGAGAAGGACCTGATGATCGCCACGCTCAACAAG
CGCGTCGCGTCATTGGAGTCTGAGTTGGGTTCACTCCAGAGCGATACCCAGGGTGTCACC
GAGGACGTACTGACGGCCATTTCGGCCGTTGCGGCCTATCTCGGCAACGATGGATCGGCT
GAGGTCGTCCATTTCGCCCCGAGCCCGAACTGGGTCCGCGAGGGTCGTCGGGCTCTGCAG
AACCATTCCATTCGTTGA

# Drug_Target_1_General_Function:
Involved in oxidoreductase activity

# Drug_Target_1_General_References:
8366018	Thornton CG, Kumar GK, Haase FC, Phillips NF, Woo SB, Park VM, Magner WJ, Shenoy BC, Wood HG, Samols D: Primary structure of the monomer of the 12S subunit of transcarboxylase as deduced from DNA and characterization of the product expressed in Escherichia coli. J Bacteriol. 1993 Sep;175(17):5301-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3240

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
65927

# Drug_Target_1_Name:
Methylmalonyl-CoA carboxyltransferase 12S subunit

# Drug_Target_1_Number_of_Residues:
611

# Drug_Target_1_PDB_ID:
1ON9

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01039	Carboxyl_trans

# Drug_Target_1_Protein_Sequence:
>Methylmalonyl-CoA carboxyltransferase 12S subunit
MAENNNLKLASTMEGRVEQLAEQRQVIEAGGGERRVEKQHSQGKQTARERLNNLLDPHSF
DEVGAFRKHRTTLFGMDKAVVPADGVVTGRGTILGRPVHAASQDFTVMGGSAGETQSTKV
VETMEQALLTGTPFLFFYDSGGARIQEGIDSLSGYGKMFFANVKLSGVVPQIAIIAGPCA
GGASYSPALTDFIIMTKKAHMFITGPQVIKSVTGEDVTADELGGAEAHMAISGNIHFVAE
DDDAAELIAKKLLSFLPQNNTEEASFVNPNNDVSPNTELRDIVPIDGKKGYDVRDVIAKI
VDWGDYLEVKAGYATNLVTAFARVNGRSVGIVANQPSVMSGCLDINASDKAAEFVNFCDS
FNIPLVQLVDVPGFLPGVQQEYGGIIRHGAKMLYAYSEATVPKITVVLRKAYGGSYLAMC
NRDLGADAVYAWPSAEIAVMGAEGAANVIFRKEIKAADDPDAMRAEKIEEYQNAFNTPYV
AAARGQVDDVIDPADTRRKIASALEMYATKRQTRPAKKPWKLPLLSEEEIMADEEEKDLM
IATLNKRVASLESELGSLQSDTQGVTEDVLTAISAVAAYLGNDGSAEVVHFAPSPNWVRE
GRRALQNHSIR

# Drug_Target_1_Reaction:
(S)-methylmalonyl-CoA + pyruvate = propanoyl-CoA + oxaloacetate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
The 12S subunit specifically catalyzes the transfer of the carboxyl group of methylmalonyl CoA to the biotin of the 1.3S subunit forming propanoyl-CoA and carboxylated 1.3S-biotin

# Drug_Target_1_SwissProt_ID:
Q8GBW6

# Drug_Target_1_SwissProt_Name:
12S_PROFR

# Drug_Target_1_Synonyms:
EC 2.1.3.1
Transcarboxylase 12S subunit

# Drug_Target_1_Theoretical_pI:
4.86

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04045
